Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-22-024519

EVP, Drug Development gave up 2,012 shares (to pay taxes)

  • EVP, Drug Development acquired 5,814 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
MANHARD KIMBERLY EVP, Drug Development 2022-04-13 Option exercise +1,250 8,320 D
MANHARD KIMBERLY EVP, Drug Development 2022-04-13 Option exercise +4,564 12,884 D
MANHARD KIMBERLY EVP, Drug Development 2022-04-13 Shares withheld for taxes −2,012 $6.07 $12,213 10,872 D
Derivatives
MANHARD KIMBERLY EVP, Drug Development 2022-04-13 Option exercise · Restricted Stock Units −1,250 12,500 D
MANHARD KIMBERLY EVP, Drug Development 2022-04-13 Option exercise · Restricted Stock Units −4,564 46,192 D
Loading xslF345X03/doc4.xml…